These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1876785)

  • 41. Comparative study on the bioequivalence of two formulations of pravastatin. Data from a crossover, randomised, open-label bioequivalence study in healthy volunteers.
    Almeida S; Filipe A; Almeida A; Gich I; Antonijoan R; Puntes M; Barbanoj M; Cruz Caturla M
    Arzneimittelforschung; 2006; 56(2):70-5. PubMed ID: 16572920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measuring switchability and prescribability: when is average bioequivalence sufficient?
    Hauck WW; Anderson S
    J Pharmacokinet Biopharm; 1994 Dec; 22(6):551-64. PubMed ID: 7473081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Equivalence tests for interchangeability based on two one-sided probabilities.
    Dong X; Tsong Y; Shen M
    J Biopharm Stat; 2014; 24(6):1332-48. PubMed ID: 25033074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioequivalence and intrasubject variability.
    Liu JP
    J Biopharm Stat; 1991; 1(2):205-19. PubMed ID: 1844697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers.
    Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C
    Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On a reasonable disaggregate criterion of population bioequivalence admitting of resampling-free testing procedures.
    Wellek S
    Stat Med; 2000 Oct; 19(20):2755-67. PubMed ID: 11033573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental design and statistical methods for classical and bioequivalence hypothesis testing with an application to dairy nutrition studies.
    Tempelman RJ
    J Anim Sci; 2004; 82 E-Suppl():E162-172. PubMed ID: 15471796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioequivalence evaluation of three different oral formulations of ciprofloxacin in healthy volunteers.
    Maya MT; Gonçalves NJ; Silva NE; Filipe AE; Morais JA
    Eur J Drug Metab Pharmacokinet; 2003; 28(2):129-36. PubMed ID: 12877571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mean difference vs. variability reduction: tradeoffs in aggregate measures for individual bioequivalence. FDA Individual Bioequivalence Working Group.
    Hauck WW; Chen ML; Hyslop T; Patnaik R; Schuirmann D; Williams R
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):535-41. PubMed ID: 8996848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subject-by-formulation interaction in bioequivalence: conceptual and statistical issues. FDA Population/Individual Bioequivalence Working Group. Food and Drug Administration.
    Hauck WW; Hyslop T; Chen ML; Patnaik R; Williams RL
    Pharm Res; 2000 Apr; 17(4):375-80. PubMed ID: 10870978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minimum sample size and sampling time requirements for assessment of rifampicin bioequivalence from FDC formulations.
    Agrawal S; Kaur KJ; Singh I; Bhade S; Kaul CL; Panchagnula R
    Int J Tuberc Lung Dis; 2005 Nov; 9(11):1273-80. PubMed ID: 16333937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A modified large sample approach in the assessment of population bioequivalence.
    Quiroz J; Ting N; Wei GC; Burdick RK
    J Biopharm Stat; 2000 Nov; 10(4):527-44. PubMed ID: 11104391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [New guidelines for the assessment of bioavailability and bioequivalence].
    Blume H; Schug B; Tautz J; Erb K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):548-55. PubMed ID: 15887065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
    Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioequivalence evaluation of two formulations of pidotimod using a limited sampling strategy.
    Huang JH; Huang XH; Wang K; Li JC; Xie XF; Shen CL; Li LJ; Zheng QS
    Biomed Pharmacother; 2013 Jul; 67(6):475-80. PubMed ID: 23639228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioequivalence evaluation of two brands of lisinopril tablets by in vitro comparative dissolution test and in vivo bioequivalence test.
    Shin MC; Kim JK; Kim CK
    Arzneimittelforschung; 2008; 58(1):11-7. PubMed ID: 18368945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levothyrox
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran A; Toutain PL
    Clin Pharmacokinet; 2019 Jul; 58(7):827-833. PubMed ID: 30949873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers.
    Piñeyro-López A; Piñeyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez-Silva M; Waksman N; E Salazar-Leal M; Luján-Rangel R
    Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Individual bioequivalence revisited.
    Chen ML; Lesko LJ
    Clin Pharmacokinet; 2001; 40(10):701-6. PubMed ID: 11707058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and bioequivalence study of two mosapride citrate formulations after single-dose administration in healthy Chinese male volunteers.
    Huang J; Tian Y; Zhang ZJ; Li J; Cao X
    Arzneimittelforschung; 2011; 61(3):167-72. PubMed ID: 21528641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.